The drug is currently classified by the U.S. (Case No. (Case No. As our Firm is currently investigat...

1. Zofran Lawsuit Filings in Massachusetts, Texas Latest to
Allege Anti-Nausea Drug May Cause Birth Defects,
According to Bernstein Liebhard LLP | Reuters
The drug is currently classified by the U.S. (Case No. (Case No. As our Firm is currently
investigating similar allegations on behalf of a number of clients, we will continue to closely monitor
developments in this growing litigation," Sandy A. (Case 2:15-cv-00544-JEO) On April 3rd, a Zofran
lawsuit was filed in the U.S. RG15761042). A complaint filed on February 16th in U.S. To find out
more
http://www.zofranlawsuit2015.com/zofran-lawyer/ about available legal options, please visit
Bernstein Liebhard LLP's website, or call the Firm directly at (888) 340-4807.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in
complex individual and class action lawsuits nationwide since 1993. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.zofranlawsuit2015.com/
https://plus.google.com/115936073311125306742?rel=author
Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-
releases/zofran-lawsuit-filings-in-massachusetts-texas-latest-to-allege-anti-nausea-d-
ug-may-cause-birth-defects-according-to-bernstein-liebhard-llp-300069653.html
SOURCE Bernstein Liebhard LLP
. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of
defective drugs and medical devices. District Court, Eastern District of Texas, claims that pre-natal
exposure to Zofran during the first trimester of pregnancy caused a child to suffer a number of
congenital abnormalities, including a heart murmur, fluid on the brain, thickened arteries and
multiple developmental delays. (Case No. Bernstein Liebhard LLP is the only firm in the country to
be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(888) 340-4807

2. ATTORNEY ADVERTISING. DRU-1505-14)
"The allegations in these two complaints regarding the tactics GlaxoSmithKline used to market
Zofran are strikingly similar to those included in a number of other birth defect lawsuits involving
the mediation that have been filed in recent months. Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
Contact Information:
Sandy A. (1:15-cv-00026-SPW-CSO)
Other Zofran lawsuits include a case filed on March 6th in California's Alameda Superior Court that
alleges prenatal Zofran exposure caused a little boy to suffer a heart rhythm problem called
supraventricular tachycardia.
PR Newswire
NEW YORK, April 21, 2015
NEW YORK, April 21, 2015 /PRNewswire/ -- Zofran lawsuits (http://www.zofranlawsuit2015.com/ )
that allege the anti-nausea medication may cause serious birth defects when it is used to treat
expectant mothers during their first trimester of pregnancy continue to mount in courts around the
U.S. courts. District Court, Northern District of Alabama, which alleges Zofran was responsible for a
number of congenital defects. Food Drug Administration in Pregnancy Category B, which indicates
its effects in pregnant women have not been well studied. As a national law firm, Bernstein Liebhard
LLP possesses all of the legal and financial resources required to successfully challenge billion dollar
pharmaceutical and medical device companies. District Court, District of Montana, which claims
first-trimester Zofran use caused a child to be born with a cleft palate. District Court, Eastern
District of Pennsylvania. (Case 2:15-cv-00709-PDC)
Children who http://www.drugwatch.com/zofran/ allegedly suffered serious birth defects due to their
mother's use of Zofran during the first trimester of pregnancy may be entitled to compensation from
GlaxoSmithKline. The National Law Journal has recognized Bernstein Liebhard for twelve
consecutive years as one of the top plaintiffs' firms in the country. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (888)
340-4807. Both of the Zofran lawsuits pending in Massachusetts and California allege that
GlaxoSmithKline fraudulently marketed the medication as a safe and effective treatment for morning
sickness, even though the company had never conducted studies to investigate its effects on
pregnant women. (Case 1:15-cv-10429) Two other children are alleged to have suffered Zofran-
related heart defects in a case that was filed on February zofran birth defects lawyer 12th in the
U.S. Finally, the complaints claim that Glaxo has received at least 200 reports since 1992 of birth
defects related to Zofran.

3. Court records indicate that these two new filings are among at least a half dozen Zofran lawsuits
involving birth defect that are currently pending in U.S. The Firm is now accepting inquiries from
families whose child was allegedly born with a serious congenital abnormality due to pre-natal
exposure to Zofran.
Zofran Litigation
According to court documents, Zofran is an anti-nausea medication that has never been approved to
treat nausea and vomiting related to pregnancy. As a result, our attorneys and legal staff have been
able to recover more than $3 billion on behalf of our clients. © 2015 Bernstein Liebhard LLP. The
lawsuits further assert that Glaxo's own animal studies conducted in the 1980s indicated that Zofran
could cross the placental barrier, and revealed evidence of toxicity, intrauterine deaths and
malformations in offspring. District Court, District of Massachusetts, claims that Zofran caused a
baby girl to be born with a number of congenital abnormalities, including heart defects. These cases
include a filing made on April 1st in the U.S. According to court documents, one such lawsuit was
filed on April 17th in U.S. 1:15-11627) A second complaint filed in the U.S. District Court, District of
Massachusetts, on behalf of a woman who was forced to terminate her pregnancy after her unborn
child was diagnosed with severe fetal defects allegedly associated with Zofran